Anticholinergic activity in cerebrospinal fluid and serum in individuals with hip fracture with and without delirium

Journal of the American Geriatrics Society

Volumn 62, Issue 1, 2014, Pages 94-102

  Watne, Leiv Otto ^a,b   Hall, Roanna J ^c   Molden, Espen ^b   Ræder, Johan ^a,b   Frihagen, Frede ^a   MacLullich, Alasdair M J ^c   Juliebø, Vibeke ^a   Nyman, Armika ^b   Meagher, David ^d,e   Wyller, Torgeir B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF LIMERICK   (Ireland)

^e UNIVERSITY HOSPITAL LIMERICK   (Ireland)

Author keywords

anticholinergic activity; cerebrospinal fluid; delirium; hip fracture

Indexed keywords

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DELIRIUM; DISEASE ASSOCIATION; FEMALE; FEMUR FRACTURE; HIP FRACTURE; HOSPITAL DISCHARGE; HUMAN; INFORMANT QUESTIONNAIRE ON COGNITIVE DECLINE IN THE ELDERLY; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NORWAY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK; SPINAL ANESTHESIA; UNITED KINGDOM; UNIVERSITY HOSPITAL; VERY ELDERLY;

ANTICHOLINERGIC ACTIVITY; CEREBROSPINAL FLUID; DELIRIUM; HIP FRACTURE;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; APACHE; CHOLINERGIC ANTAGONISTS; COMORBIDITY; DELIRIUM; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES; QUESTIONNAIRES; SCOTLAND; SEVERITY OF ILLNESS INDEX;

EID: 84892832664     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12612     Document Type: Article

References (47)

1. Ryan DJ, O'Regan NA, Caoimh RO, et al. Delirium in an adult acute hospital population: Predictors, prevalence and detection. BMJ Open 2013; 3:pii: e001772. doi: 10.1136/bmjopen-2012-001772. Print 2013.
2. Bruce AJ, Ritchie CW, Blizard R, et al. The incidence of delirium associated with orthopedic surgery: A meta-analytic review. Int Psychogeriatr 2007; 19: 197-214.
3. Witlox J, Eurelings LSM, de Jonghe JFM, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia. JAMA 2010; 304: 443-451.
4. Krogseth M, Wyller TB, Engedal K, et al. Delirium is an important predictor of incident dementia among elderly hip fracture patients. Dement Geriatr Cogn Disord 2011; 31: 63-70.
5. Davis DHJ, Muniz Terrera G, Keage H, et al. Delirium is a strong risk factor for dementia in the oldest-old: A population-based cohort study. Brain 2012; 135: 2809-2816.
6. Inouye SK, Bogardus ST Jr., Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340: 669-676.
7. Marcantonio ER, Flacker JM, Wright RJ, et al. Reducing delirium after hip fracture: A randomized trial. J Am Geriatr Soc 2001; 49: 516-522.
8. MacLullich AM, Ferguson KJ, Miller T, et al. Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses. J Psychosom Res 2008; 65: 229-238.
9. Trzepacz PT,. Anticholinergic model for delirium. Semin Clin Neuropsychiatry 1996; 1: 294-303.
10. Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: A review and practical application. Aging Health 2008; 4: 311-320.
11. Tune L, Coyle JT,. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry 1980; 37: 293-297.
12. Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: A clinical review. Clin Interv Aging 2009; 4: 225-233.
13. Carnahan RM, Lund BC, Perry PJ, et al. A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice. Psychopharmacol Bull 2002; 36: 24-39.
14. Flacker JM, Cummings V, Mach JR Jr., et al. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psych 1998; 6: 31-41.
15. Plaschke K, Hill H, Engelhardt R, et al. EEG changes and serum anticholinergic activity measured in patients with delirium in the intensive care unit. Anaesthesia 2007; 62: 1217-1223.
16. van Munster BC, Thomas C, Kreisel SH, et al. Longitudinal assessment of serum anticholinergic activity in delirium of the elderly. J Psychiatr Res 2012; 46: 1339-1345.
17. Miller PS, Richardson JS, Jyu CA, et al. Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients. Am J Psychiatry 1988; 145: 342-345.
18. Plaschke K, Thomas C, Engelhardt R, et al. Significant correlation between plasma and CSF anticholinergic activity in presurgical patients. Neurosci Lett 2007; 417: 16-20.
19. Plaschke K, Kopitz J, Mattern J, et al. Increased cortisol levels and anticholinergic activity in cognitively unimpaired patients. J Neuropsychiatry Clin Neurosci 2010; 22: 433-441.
20. Wyller T, Watne L, Torbergsen A, et al. The effect of a pre- and post-operative orthogeriatric service on cognitive function in patients with hip fracture. The protocol of the Oslo Orthogeriatrics Trial. BMC Geriatr 2012; 12: 36.
21. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med 1990; 113: 941-948.
22. Breitbart W, Rosenfeld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13: 128-137.
23. Folstein MF, Folstein SE, McHugh PR,. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
24. Brown LJ, Fordyce C, Zaghdani H, et al. Detecting deficits of sustained visual attention in delirium. J Neurol Neurosurg Psychiatry 2011; 82: 1334-1340.
25. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166: 1338-1344.
26. Tieges Z, McGrath A, Hall RJ, MacLullich AMJ,. Abnormal level of arousal as a predictor of delirium and inattention: An exploratory study. Am J Geriat Psychiat 2013. doi: 10.1016j.jagp.2013.05.003
27. Trzepacz PT, Mittal D, Torres R, et al. Validation of the Delirium Rating Scale-revised-98: Comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001; 13: 229-242.
28. Jorm AF, Jacomb PA,. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19: 1015-1022.
29. Jorm AF,. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Development and cross-validation. Psychol Med 1994; 24: 145-153.
30. Jorm AF,. The informant questionnaire on cognitive decline in the elderly (IQCODE): A review. Int Psychogeriatr 2004; 16: 275-293.
31. Wade D,. Measurement in Neurological Rehabilitation. Oxford, UK: Oxford University Press, 1992.
32. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-919.
33. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
34. Adamis D, Lunn M, Martin FC, et al. Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients. Age Ageing 2008; 38: 326-332.
35. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
36. Jakobsen SMÑ, Kersten H, Molden E,. Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay. J Am Geriatr Soc 2011; 59: 501-505.
37. Mussi C, Ferrari R, Ascari S, et al. Importance of serum anticholinergic activity in the assessment of elderly patients with delirium. J Geriatr Psychiatry Neurol 1999; 12: 82-86.
38. Mach JR Jr., Dysken MW, Kuskowski M, et al. Serum anticholinergic activity in hospitalized older persons with delirium: A preliminary study. J Am Geriatr Soc 1995; 43: 491-495.
39. Golinger RC, Peet T, Tune LE,. Association of elevated plasma anticholinergic activity with delirium in surgical patients. Am J Psychiatry 1987; 144: 1218-1220.
40. Tune L, Holland A, Folstein M, et al. Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 1981; 2: 651-653.
41. Flacker JM, Lipsitz LA,. Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol A Biol Sci Med Sci 1999; 54A: M12-M16.
42. Thomas C, Hestermann U, Kopitz J, et al. Serum anticholinergic activity and cerebral cholinergic dysfunction: An EEG study in frail elderly with and without delirium. BMC Neurosci 2008; 9: 86.
43. Chew ML, Mulsant BH, Pollock BG,. Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. Am J Geriatr Psych 2005; 13: 535-538.
44. Juliebo V, Bjoro K, Krogseth M, et al. Risk factors for preoperative and postoperative delirium in elderly patients with hip fracture. J Am Geriatr Soc 2009; 57: 1354-1361.
45. Morandi A, Barnett N, Miller RR 3rd, et al. Vitamin D and delirium in critically ill patients: A preliminary investigation. J Crit Care 2013; 28: 230-235.
46. Broussard GJ, Mytar J, Li RC, et al. The role of inflammatory processes in Alzheimer's disease. Inflammopharmacology 2012; 20: 109-126.
47. Field RH, Gossen A, Cunningham C,. Prior pathology in the basal forebrain cholinergic system predisposes to inflammation-induced working memory deficits: Reconciling inflammatory and cholinergic hypotheses of delirium. J Neurosci 2012; 32: 6288-6294.